Seeking patients who have taken part in the ALCHEMIST Screening Trial to determine mutational status
The purpose is to find out whether adding a new drug after surgery and the usual postoperative treatment can stop lung cancer from coming back.
What we're hoping for
We are hoping that the study drug may turn on the immune system to attack cancer cells left behind after surgery
ClinicalTrials.gov Identifier: NCT02595944